{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:33:21Z","timestamp":1788374001194,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI116240-01A1"],"award-info":[{"award-number":["AI116240-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3697-9","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T13:02:58Z","timestamp":1547643778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Anjali","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin B.","family":"Punke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Mehmetoglu-Gurbuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego P.","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"issue":"1","key":"3697_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/524143","volume":"197","author":"PW Hunt","year":"2008","unstructured":"Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197(1):126\u201333.","journal-title":"J Infect Dis"},{"issue":"4","key":"3697_CR2","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.4049\/jimmunol.1501588","volume":"196","author":"A Joshi","year":"2016","unstructured":"Joshi A, Sedano M, Beauchamp B, Punke EB, Mulla ZD, Meza A, Alozie OK, Mukherjee D, Garg H. HIV-1 Env glycoprotein phenotype along with immune activation determines CD4 T cell loss in HIV patients. J Immunol. 2016;196(4):1768\u201379.","journal-title":"J Immunol"},{"issue":"2","key":"3697_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/path.2276","volume":"214","author":"V Appay","year":"2008","unstructured":"Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol. 2008;214(2):231\u201341.","journal-title":"J Pathol"},{"issue":"1","key":"3697_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V95.1.249","volume":"95","author":"MD Hazenberg","year":"2000","unstructured":"Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood. 2000;95(1):249\u201355.","journal-title":"Blood"},{"issue":"1","key":"3697_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","volume":"254","author":"M Paiardini","year":"2013","unstructured":"Paiardini M, Muller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254(1):78\u2013101.","journal-title":"Immunol Rev"},{"issue":"12","key":"3697_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365\u201371.","journal-title":"Nat Med"},{"issue":"2","key":"3697_CR7","doi-asserted-by":"publisher","first-page":"e30881","DOI":"10.1371\/journal.pone.0030881","volume":"7","author":"A Kamat","year":"2012","unstructured":"Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, Li C, Morgello S, Gabuzda D. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One. 2012;7(2):e30881.","journal-title":"PLoS One"},{"key":"3697_CR8","doi-asserted-by":"crossref","unstructured":"Scagnolari C, Antonelli G. Type I interferon and HIV: subtle balance between antiviral activity, immunopathogenesis and the microbiome. Cytokine Growth Factor Rev. 2018.","DOI":"10.1016\/j.cytogfr.2018.03.003"},{"issue":"4","key":"3697_CR9","first-page":"128","volume":"21","author":"DC Douek","year":"2013","unstructured":"Douek DC. Immune activation, HIV persistence, and the cure. Topics in antiviral medicine. 2013;21(4):128\u201332.","journal-title":"Topics in antiviral medicine"},{"issue":"10","key":"3697_CR10","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/374786","volume":"187","author":"PW Hunt","year":"2003","unstructured":"Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003;187(10):1534\u201343.","journal-title":"J Infect Dis"},{"issue":"9","key":"3697_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.194.9.1277","volume":"194","author":"H Mohri","year":"2001","unstructured":"Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, Kost R, Hurley A, Weinberger L, Cesar D, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med. 2001;194(9):1277\u201387.","journal-title":"J Exp Med"},{"issue":"12","key":"3697_CR12","doi-asserted-by":"publisher","first-page":"e1004543","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog. 2014;10(12):e1004543.","journal-title":"PLoS Pathog"},{"issue":"4","key":"3697_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nm.2111","volume":"16","author":"MJ Buzon","year":"2010","unstructured":"Buzon MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010;16(4):460\u20135.","journal-title":"Nat Med"},{"issue":"11","key":"3697_CR14","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","volume":"115","author":"AS Beignon","year":"2005","unstructured":"Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J Clin Invest. 2005;115(11):3265\u201375.","journal-title":"J Clin Invest"},{"issue":"7","key":"3697_CR15","doi-asserted-by":"publisher","first-page":"e1004291","DOI":"10.1371\/journal.ppat.1004291","volume":"10","author":"G Li","year":"2014","unstructured":"Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, Liu YJ, Su L, Zhang L. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10(7):e1004291.","journal-title":"PLoS Pathog"},{"key":"3697_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","volume":"21","author":"K Takeda","year":"2003","unstructured":"Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335\u201376.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"3697_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/nm.1871","volume":"14","author":"JN Mandl","year":"2008","unstructured":"Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008;14(10):1077\u201387.","journal-title":"Nat Med"},{"issue":"10","key":"3697_CR18","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.4049\/jimmunol.170.10.5159","volume":"170","author":"O Equils","year":"2003","unstructured":"Equils O, Schito ML, Karahashi H, Madak Z, Yarali A, Michelsen KS, Sher A, Arditi M. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J Immunol. 2003;170(10):5159\u201364.","journal-title":"J Immunol"},{"issue":"4","key":"3697_CR19","doi-asserted-by":"publisher","first-page":"e1915","DOI":"10.1371\/journal.pone.0001915","volume":"3","author":"N Funderburg","year":"2008","unstructured":"Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, Lederman MM. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One. 2008;3(4):e1915.","journal-title":"PLoS One"},{"issue":"12","key":"3697_CR20","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood-2011-01-329060","volume":"118","author":"S Piconi","year":"2011","unstructured":"Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, et al. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood. 2011;118(12):3263\u201372.","journal-title":"Blood"},{"issue":"4","key":"3697_CR21","doi-asserted-by":"publisher","first-page":"e1005553","DOI":"10.1371\/journal.ppat.1005553","volume":"12","author":"M O\u2019Brien","year":"2016","unstructured":"O\u2019Brien M, Manches O, Wilen C, Gopal R, Huq R, Wu V, Sunseri N, Bhardwaj N. CD4 receptor is a key determinant of divergent HIV-1 sensing by Plasmacytoid dendritic cells. PLoS Pathog. 2016;12(4):e1005553.","journal-title":"PLoS Pathog"},{"issue":"47","key":"3697_CR22","doi-asserted-by":"publisher","first-page":"14658","DOI":"10.1073\/pnas.1514867112","volume":"112","author":"PJ McLaren","year":"2015","unstructured":"McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A. 2015;112(47):14658\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3697_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2(8):675\u201380.","journal-title":"Nat Immunol"},{"issue":"10","key":"3697_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5(10):987\u201395.","journal-title":"Nat Immunol"},{"key":"3697_CR25","doi-asserted-by":"publisher","first-page":"381418","DOI":"10.1155\/2014\/381418","volume":"2014","author":"A Klonowska-Szymczyk","year":"2014","unstructured":"Klonowska-Szymczyk A, Wolska A, Robak T, Cebula-Obrzut B, Smolewski P, Robak E. Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Mediat Inflamm. 2014;2014:381418.","journal-title":"Mediat Inflamm"},{"key":"3697_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1475-2875-11-168","volume":"11","author":"AH Omar","year":"2012","unstructured":"Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K. Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malar J. 2012;11:168.","journal-title":"Malar J"},{"key":"3697_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2334-12-112","volume":"12","author":"MS Sanders","year":"2012","unstructured":"Sanders MS, van Well GT, Ouburg S, Morre SA, van Furth AM. Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors. BMC Infect Dis. 2012;12:112.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"3697_CR28","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s10096-015-2461-3","volume":"34","author":"W Wujcicka","year":"2015","unstructured":"Wujcicka W, Gaj Z, Wilczynski J, Nowakowska D. Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2015;34(10):2121\u20139.","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"issue":"4","key":"3697_CR29","doi-asserted-by":"publisher","first-page":"e0122831","DOI":"10.1371\/journal.pone.0122831","volume":"10","author":"W Wujcicka","year":"2015","unstructured":"Wujcicka W, Paradowska E, Studzinska M, Gaj Z, Wilczynski J, Lesnikowski Z, Nowakowska D. TLR9 2848 GA heterozygotic status possibly predisposes fetuses and newborns to congenital infection with human cytomegalovirus. PLoS One. 2015;10(4):e0122831.","journal-title":"PLoS One"},{"issue":"10","key":"3697_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/infdis\/jit807","volume":"209","author":"RD Mackelprang","year":"2014","unstructured":"Mackelprang RD, Bigham AW, Celum C, de Bruyn G, Beima-Sofie K, John-Stewart G, Ronald A, Mugo NR, Buckingham KJ, Bamshad MJ, et al. Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans. J Infect Dis. 2014;209(10):1623\u20137.","journal-title":"J Infect Dis"},{"key":"3697_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/1471-2334-13-511","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Li X, Cui W, Guan L, Shen F, Xu J, Zhou F, Li M, Gao C, Jin Q, et al. Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population. BMC Infect Dis. 2013;13:511.","journal-title":"BMC Infect Dis"},{"key":"3697_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1479-5876-8-49","volume":"8","author":"E Ricci","year":"2010","unstructured":"Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C, De Rossi A. Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med. 2010;8:49.","journal-title":"J Transl Med"},{"issue":"4","key":"3697_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/QAD.0b013e328012b8ac","volume":"21","author":"PY Bochud","year":"2007","unstructured":"Bochud PY, Hersberger M, Taffe P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, et al. Polymorphisms in toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS. 2007;21(4):441\u20136.","journal-title":"AIDS"},{"issue":"6","key":"3697_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/QAD.0b013e3283514350","volume":"26","author":"R Freguja","year":"2012","unstructured":"Freguja R, Gianesin K, Del Bianco P, Malacrida S, Rampon O, Zanchetta M, Giaquinto C, De Rossi A. Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. AIDS. 2012;26(6):765\u20138.","journal-title":"AIDS"},{"issue":"1","key":"3697_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.imlet.2014.04.005","volume":"160","author":"EA Said","year":"2014","unstructured":"Said EA, Al-Yafei F, Zadjali F, Hasson SS, Al-Balushi MS, Al-Mahruqi S, Koh CY, Al-Naamani K, Al-Busaidi JZ, Idris MA, et al. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A\/G) with a higher CD4T cell count during HIV infection. Immunol Lett. 2014;160(1):58\u201364.","journal-title":"Immunol Lett"},{"issue":"2","key":"3697_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/QAI.0b013e318184fb41","volume":"49","author":"N Soriano-Sarabia","year":"2008","unstructured":"Soriano-Sarabia N, Vallejo A, Ramirez-Lorca R, Rodriguez Mdel M, Salinas A, Pulido I, Saez ME, Leal M. Influence of the toll-like receptor 9 1635A\/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr. 2008;49(2):128\u201335.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"3697_CR37","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1097\/QAD.0b013e328330b489","volume":"23","author":"SO Pine","year":"2009","unstructured":"Pine SO, McElrath MJ, Bochud PY. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS. 2009;23(18):2387\u201395.","journal-title":"AIDS"},{"issue":"15","key":"3697_CR38","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1097\/QAD.0b013e3283629117","volume":"27","author":"KM Beima-Sofie","year":"2013","unstructured":"Beima-Sofie KM, Bigham AW, Lingappa JR, Wamalwa D, Mackelprang RD, Bamshad MJ, Maleche-Obimbo E, Richardson BA, John-Stewart GC. Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level. AIDS. 2013;27(15):2431\u20139.","journal-title":"AIDS"},{"issue":"7","key":"3697_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/ard.2006.065961","volume":"66","author":"K Tao","year":"2007","unstructured":"Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, et al. Genetic variations of toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007;66(7):905\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3697_CR40","doi-asserted-by":"crossref","unstructured":"Gebura K, Swierkot J, Wysoczanska B, Korman L, Nowak B, Wiland P, Bogunia-Kubik K. Polymorphisms within genes involved in regulation of the NF-kappaB pathway in patients with rheumatoid arthritis. Int J Mol Sci. 2017;18(7).","DOI":"10.3390\/ijms18071432"},{"issue":"12","key":"3697_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00251-014-0806-1","volume":"66","author":"D Bharti","year":"2014","unstructured":"Bharti D, Kumar A, Mahla RS, Kumar S, Ingle H, Shankar H, Joshi B, Raut AA, Kumar H. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics. 2014;66(12):675\u201381.","journal-title":"Immunogenetics"},{"issue":"6","key":"3697_CR42","doi-asserted-by":"publisher","first-page":"e65731","DOI":"10.1371\/journal.pone.0065731","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang X, Xue L, Yang Y, Xu L, Zhang G. TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. PLoS One. 2013;8(6):e65731.","journal-title":"PLoS One"},{"issue":"1","key":"3697_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41598-017-00192-x","volume":"7","author":"A Joshi","year":"2017","unstructured":"Joshi A, Punke EB, Sedano M, Beauchamp B, Patel R, Hossenlopp C, Alozie OK, Gupta J, Mukherjee D, Garg H. CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis. Sci Rep. 2017;7(1):232.","journal-title":"Sci Rep"},{"issue":"11","key":"3697_CR44","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3390\/v4113020","volume":"4","author":"H Garg","year":"2012","unstructured":"Garg H, Mohl J, Joshi A. HIV-1 induced bystander apoptosis. Viruses. 2012;4(11):3020\u201343.","journal-title":"Viruses"},{"issue":"4","key":"3697_CR45","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1128\/JVI.01573-14","volume":"89","author":"RD Mackelprang","year":"2015","unstructured":"Mackelprang RD, Carrington M, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, Fife K, Campbell MS, Kapiga S, et al. Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa. J Virol. 2015;89(4):2104\u201311.","journal-title":"J Virol"},{"issue":"4","key":"3697_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/QAD.0b013e3282f2dbe7","volume":"22","author":"DL Sodora","year":"2008","unstructured":"Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS. 2008;22(4):439\u201346.","journal-title":"AIDS"},{"key":"3697_CR47","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3389\/fimmu.2017.01925","volume":"8","author":"L Pastor","year":"2017","unstructured":"Pastor L, Urrea V, Carrillo J, Parker E, Fuente-Soro L, Jairoce C, Mandomando I, Naniche D, Blanco J. Dynamics of CD4 and CD8 T-cell subsets and inflammatory biomarkers during early and chronic HIV infection in Mozambican adults. Front Immunol. 2017;8:1925.","journal-title":"Front Immunol"},{"issue":"4","key":"3697_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/aid.2010.0342","volume":"27","author":"G d\u2019Ettorre","year":"2011","unstructured":"d\u2019Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V. HIV-associated immune activation: from bench to bedside. AIDS Res Hum Retrovir. 2011;27(4):355\u201364.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"3697_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/09680519040100060901","volume":"10","author":"J Vollmer","year":"2004","unstructured":"Vollmer J, Jurk M, Samulowitz U, Lipford G, Forsbach A, Wullner M, Tluk S, Hartmann H, Kritzler A, Muller C, et al. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells. J Endotoxin Res. 2004;10(6):431\u20138.","journal-title":"J Endotoxin Res"},{"issue":"8","key":"3697_CR50","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.4049\/jimmunol.170.8.4061","volume":"170","author":"SE Blackwell","year":"2003","unstructured":"Blackwell SE, Krieg AM. CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. J Immunol. 2003;170(8):4061\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"3697_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3851\/IMP1917","volume":"17","author":"JM Llibre","year":"2012","unstructured":"Llibre JM, Buzon MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, et al. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. Antivir Ther. 2012;17(2):355\u201364.","journal-title":"Antivir Ther"},{"issue":"1","key":"3697_CR52","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1038\/s41598-017-08218-0","volume":"7","author":"L Pastor","year":"2017","unstructured":"Pastor L, Casellas A, Carrillo J, Alonso S, Parker E, Fuente-Soro L, Jairoce C, Mandomando I, Blanco J, Naniche D. IP-10 levels as an accurate screening tool to detect acute HIV infection in resource-limited settings. Sci Rep. 2017;7(1):8104.","journal-title":"Sci Rep"},{"issue":"4","key":"3697_CR53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00296-015-3404-0","volume":"36","author":"D Wang","year":"2016","unstructured":"Wang D, Zhang C, Zhou Z, Pei F. TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study. Rheumatol Int. 2016;36(4):585\u201395.","journal-title":"Rheumatol Int"},{"key":"3697_CR54","doi-asserted-by":"crossref","unstructured":"Garg H, Joshi A. Host and viral factors in HIV-mediated bystander apoptosis. Viruses. 2017;9(8).","DOI":"10.3390\/v9080237"},{"issue":"3","key":"3697_CR55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1074-7613(03)00060-8","volume":"18","author":"G Silvestri","year":"2003","unstructured":"Silvestri G, Sodora DL, Koup RA, Paiardini M, O\u2019Neil SP, McClure HM, Staprans SI, Feinberg MB. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity. 2003;18(3):441\u201352.","journal-title":"Immunity"},{"issue":"2","key":"3697_CR56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1128\/JVI.01715-08","volume":"83","author":"M Meythaler","year":"2009","unstructured":"Meythaler M, Martinot A, Wang Z, Pryputniewicz S, Kasheta M, Ling B, Marx PA, O\u2019Neil S, Kaur A. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol. 2009;83(2):572\u201383.","journal-title":"J Virol"},{"issue":"6","key":"3697_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ni.2284","volume":"13","author":"MG Netea","year":"2012","unstructured":"Netea MG, Wijmenga C, O\u2019Neill LA. Genetic variation in toll-like receptors and disease susceptibility. Nat Immunol. 2012;13(6):535\u201342.","journal-title":"Nat Immunol"},{"issue":"8","key":"3697_CR58","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/597476","volume":"199","author":"W Jiang","year":"2009","unstructured":"Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, Landay A, Martin J, Sinclair E, Asher AI, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009;199(8):1177\u201385.","journal-title":"J Infect Dis"},{"issue":"22","key":"3697_CR59","doi-asserted-by":"publisher","first-page":"12082","DOI":"10.1128\/JVI.01466-10","volume":"84","author":"SM Murray","year":"2010","unstructured":"Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, Schacker TW, Brenchley JM, Douek DC. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol. 2010;84(22):12082\u20136.","journal-title":"J Virol"},{"issue":"2","key":"3697_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cei.12578","volume":"180","author":"C Skevaki","year":"2015","unstructured":"Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol. 2015;180(2):165\u201377.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"3697_CR61","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1086\/590440","volume":"198","author":"FM Leoratti","year":"2008","unstructured":"Leoratti FM, Farias L, Alves FP, Suarez-Mutis MC, Coura JR, Kalil J, Camargo EP, Moraes SL, Ramasawmy R. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis. 2008;198(5):772\u201380.","journal-title":"J Infect Dis"},{"issue":"2","key":"3697_CR62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/trf.12263","volume":"54","author":"M Morgand","year":"2014","unstructured":"Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, et al. High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French thrombotic Microangiopathies reference center. Transfusion. 2014;54(2):389\u201397.","journal-title":"Transfusion"},{"issue":"4","key":"3697_CR63","doi-asserted-by":"publisher","first-page":"e0154100","DOI":"10.1371\/journal.pone.0154100","volume":"11","author":"E Paradowska","year":"2016","unstructured":"Paradowska E, Jablonska A, Studzinska M, Skowronska K, Suski P, Wisniewska-Ligier M, Wozniakowska-Gesicka T, Nowakowska D, Gaj Z, Wilczynski J, et al. TLR9 -1486T\/C and 2848C\/T SNPs are associated with human cytomegalovirus infection in infants. PLoS One. 2016;11(4):e0154100.","journal-title":"PLoS One"},{"issue":"8","key":"3697_CR64","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1590\/S0074-02762009000800019","volume":"104","author":"AL Peixoto-Rangel","year":"2009","unstructured":"Peixoto-Rangel AL, Miller EN, Castellucci L, Jamieson SE, Peixe RG, Elias Lde S, Correa-Oliveira R, Bahia-Oliveira LM, Blackwell JM. Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Memorias do Instituto Oswaldo Cruz. 2009;104(8):1187\u201390.","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"10","key":"3697_CR65","doi-asserted-by":"publisher","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","volume":"7","author":"AS Liovat","year":"2012","unstructured":"Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barre-Sinoussi F, Lebon P, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7(10):e46143.","journal-title":"PLoS One"},{"issue":"4","key":"3697_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/QAD.0000000000000174","volume":"28","author":"N Noel","year":"2014","unstructured":"Noel N, Boufassa F, Lecuroux C, Saez-Cirion A, Bourgeois C, Dunyach-Remy C, Goujard C, Rouzioux C, Meyer L, Pancino G, et al. Elevated IP10 levels are associated with immune activation and low CD4(+) T-cell counts in HIV controller patients. AIDS. 2014;28(4):467\u201376.","journal-title":"AIDS"},{"issue":"10","key":"3697_CR67","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/cix600","volume":"65","author":"L Pastor","year":"2017","unstructured":"Pastor L, Casellas A, Ruperez M, Carrillo J, Maculuve S, Jairoce C, Paredes R, Blanco J, Naniche D. Interferon-gamma-inducible protein 10 (IP-10) as a screening tool to optimize human immunodeficiency virus RNA monitoring in resource-limited settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017;65(10):1670\u20135.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3697-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:07:29Z","timestamp":1720930049000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3697-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3697"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3697-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Texas Tech University Health Sciences Center\u2019s regional Institutional Review Board (IRB). All methods were performed in accordance with the relevant guidelines and regulations. The study design was cross-sectional and the study number recorded as IRB# E12092, approval date 07\/31\/2012. All participants were provided with written and oral information about the study. Written informed consent of all study participants in accordance with the Institutional policy was documented. All participants were identified by coded numbers to assure anonymity and all patient records kept confidential.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial and\/or non-financial interests in relation to the work described.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}